• EU Panel Votes to Import Genetically Engineered Material in Animal Feed

    Updated: 2011-02-28 05:13:56
    (Beyond Pesticides, February 28, 2010) The European Union (EU) standing committee on Tuesday decided to allow a 0.1 percent contamination threshold for unauthorized Genetically Engineered (GE) products in animal feed imports that would change the bloc’s zero-tolerance attitude toward biotech food. The EU Commission and Parliament are expected to accept the rule by this summer. [...]

  • Avastin Shows Benefits in Phase III Ovarian Cancer Study

    Updated: 2011-02-25 16:37:30
    Biotechnology from bench to business Log In Register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products

  • Alarming World-Wide Rise of Genetically Engineered Crops

    Updated: 2011-02-24 13:54:43
    (Beyond Pesticides, February 24, 2011) After 15 years of commercialization, accumulated Genetically Engineered (GE) crops in the world exceeded 1 billion hectares in 2010. For comparison, 1 billion hectares is roughly equivalent to the vast land area of China, or of the United States. The figures are in this year’s International Service for the Acquisition [...]

  • AMA Opposes Personal Genetic Testing Freedom

    Updated: 2011-02-24 04:57:20
    In a letter to the US Food and Drug Administration the American Medical Association argues that you should have to pay for a doctor's visit to get your genes tested. We need to speak out loudly and repeatedly against the efforts of regulators and economically interested parties to restrict our choices and access to tests. Some newly elected Congress critters looking to make a mark could do something useful by introducing legislation to curb the FDA's power to block direct-to-consumer (DTC) genetic testing services. We urge the Panel to offer clear findings and recommendations that genetic testing, except under the most limited circumstances, should be carried out under the personal supervision of a qualified health care professional, and provide individuals...

  • No title

    Updated: 2011-02-23 17:57:20
    Biotechnology from bench to business Log In Register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products

  • No title

    Updated: 2011-02-23 17:57:20
    Biotechnology from bench to business Log In Register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products

  • Nonsuppressive Drug Therapy for HIV

    Updated: 2011-02-23 17:57:19
    Biotechnology from bench to business Log In Register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products

  • President Obama Proposes Budget Increases for NIH CDC NSF and FDA

    Updated: 2011-02-16 15:56:29
    , , , Biotechnology from bench to business Log In Register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products

  • Unlocking Peptides†Therapeutic Potential through Proper Management of Bioanalysis

    Updated: 2011-02-04 22:18:34
    Biotechnology from bench to business Log In Register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products

  • Cryptogram Challenge Electroporation Genetic Engineering Biotechnology News Scintellix LLC

    Updated: 2011-01-31 22:04:04
    : ,

Current Feed Items | Previous Months Items

Jan 2011 | Dec 2010 | Nov 2010 | Oct 2010 | Sep 2010 | Aug 2010